0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

How to decrease pharmaceuticals in the environment? A review

Environmental Chemistry Letters 2021 156 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 60 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Magda Caban, Piotr Stepnowski

Summary

This review examines strategies for reducing pharmaceutical pollution in the environment, which is relevant to microplastic research because pharmaceuticals often co-occur with plastic contaminants in waterways. The authors ranked approaches from upstream solutions like greener drug design and better prescription practices to downstream technologies like advanced water treatment. The study concludes that preventing pharmaceutical pollution at its source is more effective and sustainable than relying solely on end-of-pipe treatment technologies.

Abstract The global problem of the presence of human and veterinary pharmaceuticals in the environment is under investigation. Despite the increase in the knowledge of its sources, fates and impacts, the assessment of risks and the derived prevention actions are limited to single cases. The predicted increasing trend in the usage of pharmaceuticals forces the various parties involved to think about comprehensive mitigation actions. There are many areas of daily human life and industrial operations where such actions should take place. Thereby, in the presented review, such actions were summarized and divided into the following groups: A. design, synthesis and production of pharmaceuticals, B. prescription, sales and waste handling, C. control of the sources with advanced technologies. As the total amount of proposed actions was found to be quite high, a ranking according to the term of effects was proposed using the pyramid of needs. The advantages of actions taken in the first steps of the pharmaceutical life cycle (acting on the upstream) over end-of-pipe actions and the application of advanced technologies (the downstream option) were discussed, with reference to expert opinions.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems

This review examines how pharmaceutical drugs are polluting waterways worldwide because conventional wastewater treatment cannot effectively remove them. The authors focus on bioremediation approaches, especially using fungi, as a more sustainable and eco-friendly way to break down these drug residues. While not directly about microplastics, the research is relevant because microplastics can carry pharmaceutical compounds in water, and better water treatment would address both contaminants.

Article Tier 2

Pharmaceuticals in the Aquatic Environment: A Review on Eco-Toxicology and the Remediation Potential of Algae

This review examines how pharmaceutical drugs end up in water through human activity and the damage they cause to aquatic life. Standard wastewater treatment plants are not designed to remove these drugs effectively, so researchers are exploring the use of algae as a low-cost, natural cleanup method. While not directly about microplastics, this is relevant because microplastics in water can absorb and transport pharmaceutical chemicals, potentially increasing human exposure.

Article Tier 2

Pharmaceutically active micropollutants: origin, hazards and removal

This review summarizes existing research on pharmaceutical pollutants -- such as antibiotics, painkillers, and hormones -- found in water systems around the world. While focused on drug contamination, the paper notes that microplastics can act as carriers for these pharmaceutical chemicals, potentially concentrating them and increasing human exposure through drinking water. Conventional water treatment methods are often unable to fully remove these micropollutants.

Systematic Review Tier 1

Micro(nano)plastics as a vector of pharmaceuticals in aquatic ecosystem: Historical review and future trends

This systematic review examines how microplastics and nanoplastics in water can absorb and carry pharmaceutical drugs, creating a combined pollution threat. When medications attach to tiny plastic particles in rivers and oceans, they may become more harmful to aquatic life and potentially to humans who consume contaminated seafood or water. The research traces how this emerging double-threat has grown since 2018 and identifies key knowledge gaps.

Article Tier 2

Pharmaceuticals in Water: Risks to Aquatic Life and Remediation Strategies

This review examines how pharmaceutical drugs in waterways threaten aquatic life and potentially human health. The biggest concern is the rise of antibiotic resistance from drugs entering water through household and agricultural waste. While not specifically about microplastics, the topic is connected because microplastics can adsorb and transport pharmaceutical residues through water systems.

Share this paper